DexCom Inc. News
5 things to know about Friday's market
And not just that the bulls are very very excited.
Stock Market Today: S&P, Dow, Nasdaq hit new highs to end week
Despite limited economic data and earnings today, momentum builds, especially in some speculative stocks.
Stock Market Today: Forget "Sell the News." Welcome Back, 4%
Investors welcomed lower interest rates with a resounding rally, which saw all U.S. stock benchmarks notch record closes.
The 5 worst performing stocks on the Nasdaq 100 in 2024
AI was huge in 2024. The underperformers list reflects challenges in the other sectors.
Stocks lower Friday. Movers: Palantir, Applied Materials, Ulta Beauty
Here are the stocks making the biggest market moves midday.
Stocks lower. Movers: Shopify, GE Vernova, Honeywell, more
Here are the stocks making the biggest market moves midday.
Stock movers: Netflix, Lamb Weston, CVS Health
Here are the stocks making the biggest market moves midday.
Midday stock movers: Boeing, Bank of America, Unity Software
Here are the stocks making the biggest market moves today.
Eli Lilly, Palo Alto up; Lowe’s down - Midday stock movers
Here are the stocks making the biggest market moves today.
Alibaba, JD.com up; Applied Materials, Amcor down - Midday stock movers
Here are the stocks making the biggest market moves today.
Midday movers: Nvidia, Apple slump; AMD, Pringles maker up
Tech stocks crashed amid AI doubt and recession fear.
Midday movers: NVIDIA, Meta, Microsoft up, diabetes stock slumps
Stocks rallied after an encouraging PCE inflation print, but not every company is a winner today.
Intuitive Surgical Isn’t The Only Attractive Healthcare Stock
Intuitive Surgical skyrocketed today, but it's not the only healthcare stock worth owning.
Apple is Making Progress on a Big Opportunity
Apple is developing its watch as a health monitoring device to include noninvasive monitoring of glucose levels.
Netflix Makes J.P Morgan's List of Pullback Stocks
Which stocks should you consider with the S&P 500 having lost 8.6% so far this year, even after its two-day rebound?
Wolfe Research's List of Companies with Pricing Power
These are companies that can raise prices without fear of losing customers as a result. The chosen companies have high margins.
Cramer's Mad Money Recap 1/10: Adobe, Zynga, Take-Two Interactive
With some parts of the stock market down sharply, Jim Cramer says investors need to take advantage of the declines and find something to buy.
Cramer's Mad Money Recap 11/9: PayPal, Nvidia, Advanced Micro Devices
Jim Cramer says he thinks he knows why the markets are rallying despite rising inflation.
Cramer's Mad Money Recap: Robinhood, Carrier Global
Jim Cramer says it sometimes pays to look past the flash and seek out the stock of solid, dependable companies we all need.
Cramer's Mad Money Recap: FAANG, Microsoft, PayPal
Jim Cramer looks at the aftermath of the Federal Reserve call, and says he sees opportunity in select tech stocks, homebuilders and fintech.
DexCom Inc. News from TheStreet Pro
Follow the Charts, Not the Science, With This Medical Device Maker
Let's check the pulse of Boston Scientific.
DexCom Stock Craters 40% After Earnings: Do the Charts Look Any Better?
Let's assess the damage here.
DexCom Looks Vulnerable Despite Forecasts of Increased Usage
The charts of the medical device maker are weakening. Here's what traders need to know.
I'm Looking to Add to 7 Stocks, Short One More
As the market sees 700 new 12-month highs and Nvidia and Alphabet attract cash, I've got these names on my radar.
Mega Caps Like Tesla, Apple Sag -- And That's Good for the Market
As we're watching a surprise reversal move in the super stocks, I've got my eyes on three names.
As DexCom Breaks Out to the Upside, Further Gains Are Expected
DXCM had a much longer sideways period than anticipated but the uptrend has resumed.
A Fresh Look at Medical Device Maker DexCom After Earnings
The shares gapped higher Friday to refresh the uptrend.
Expect Sideways Action From DexCom in the Short Run
Traders who are long the stock of the medical device company should continue to hold their shares.
We're Changing Our DexCom Strategy as the Shares Move Higher
Here's what traders should do now.
What's the DEFCON for DexCom?
Should investors fade out, do a double-take or be at the ready for a buy? Let's check the charts following a fundamental upgrade.
Dexcom's Charts Don't Make a Convincing Case for Its Shares
The stock of the maker of glucose monitoring systems may be seeking a bottom but it isn't clear whether it has gotten there yet.
The Technical Risks and Rewards of Trading DexCom Stock
DXCM is now trading above the rising 50-day moving average line and the rising 200-day line.
Jim Cramer: Google's Healthcare Deal With HCA Is Huge
The great thing about Google? Unlike IBM? It isn't trumpeting anything. It's just talking about algorithms, let the eyes glaze over.
SPAC Mania, My Short-Sale Rule, Inflation, Bumble IPO, Rivian, Trading Nvidia
Who knew high finance was so easy? And why the heck was I working so hard? Fundamental analysis is so 1980s.
A New Take on Breadth
Breadth is looking good -- unless you measure it against this index, and that's why I'm now watching closely.
DexCom Shares Could Weaken Still Further in the Months Ahead
Investors continue to be more aggressive sellers of DXCM.
DexCom Could Work Itself Lower in the Weeks Ahead
A 'careful' approach is in order for traders.
Jim Cramer: Health Care Stocks, the Election and the Perfect Setup
Right now, the market is furiously trying to price in a Blue Wave, and the health care sector is getting clobbered. But here's how I think things play out.
Breaking News
Goldman Sachs analyst revisits Rivian stock price target after Q4 earnings
Rivian's R2 SUV, which is expected to challenge Tesla's Model Y, will launch early next year.
Goldman Sachs issues surprising gold price target for 2025
The investment firm's analysts share their views about the precious metal.
UnitedHealth stock plunges on report of DoJ Medicare Advantage probe
UnitedHealth, still reeling from the murder of one of its top executives, is reportedly facing a Department of Justice investigation.
IRS makes a startling change that could impact tax returns
The federal agency has opted to make a drastic decision during a critical time of the year.











































